Forum · Biology · Story discussion
A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
4 days ago — Nature Biotechnology · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…